Brief: Biofrontera - Governmental Price Decree For Ameluz® Withdrawn In Spain

Biofrontera AG

04/04/2022 13:38

April 4 (Reuters) - BIOFRONTERA AG  B8FGn.DE :
    * GOVERNMENTAL PRICE DECREE FOR AMELUZ® WITHDRAWN IN SPAIN
    * ANNOUNCES THAT AS OF APRIL 01, 2022, DRUG PRICE OF AMELUZ
® WILL
NO LONGER BE REDUCED IN SPAIN BY WHAT BIOFRONTERA BELIEVES TO BE
AN INCORRECT PRICE DIRECTIVE
    * AS OF APRIL 01, 2022, DRUG PRICE OF AMELUZ ® WILL NO
LONGER BE
REDUCED IN SPAIN BY WHAT BIOFRONTERA BELIEVES TO BE AN INCORRECT
PRICE DIRECTIVE
    * REDUCTION CAME INTO EFFECT DUE TO WHAT BIOFRONTERA
CONSIDERED AN
INCORRECT CLASSIFICATION OF AMELUZ IN TERMS OF ACTIVE INGREDIENT
CONCENTRATION
    * DUE TO NEW REGULATIONS, CLASSIFICATION OF ACTIVE
INGREDIENTS HAS
NOW BEEN REVISED SO THAT MISCLASSIFICATION OF AMELUZ ® HAS BEEN
REMOVED AND AMELUZ ® CAN NOW BE SOLD AGAIN ON SPANISH MARKET FOR
ORIGINAL PRICE OF EUR 150
    * HAS SUBSEQUENTLY WITHDRAWN LEGAL CLAIM

Source text for Eikon:  ID:nPexGH0KWa 
Further company coverage:  B8FGn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))